Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose Derived Stromal Vascular Fraction for Keloids
NCT04391621Phase 2Unknown
- Sponsor
- Makerere University
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous adipose-derived mesenchymal stromal cells in keloid (2 arms), sponsored by Makerere University. Primary endpoint: Keloid regression at 3 months. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
keloid
Beyond the preview
Go deeper on NCT04391621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04391621.